Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood

Jenny MacLennan, Stephen Obaro, Jonathan Deeks, Derrick Williams, Lorna Pais, George Carlone, Richard Moxon, Brian Greenwood

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Forty-two Gambian children randomised to receive two doses of meningococcal A/C polysaccharide vaccine (MPS) in infancy and either MPS (n = 15), meningococcal A/C conjugate (n = 13) or inactivated polio vaccine (IPV n = 14) at 2 years, were revaccinated with MPS at 5 years of age along with 39 matched control children. Meningococcal A and C polysaccharide antibodies were analysed by ELISA and bactericidal assay (SBA) in sera taken before and 10 days after revaccination. The geometric mean group SBA titre in the MPS group following revaccination was about half that of the unvaccinated controls (0.51 95% CI: 0.28, 0.90) for group A and less than half that of the controls for group C (0.41, 95% CI: 0.16, 1.03 P = 0.06). The group C SBA response in the conjugate group was 14-fold higher than in the MPS group (P < 0.001). Multiple doses of meningococcal polysaccharide in childhood may therefore attenuate the SBA response to both group A and group C polysaccharides. In contrast, vaccination with meningococcal A/C conjugate after MPS in infancy gives immunological memory to N. meningitidis group C.

Original languageEnglish (US)
Pages (from-to)3086-3093
Number of pages8
JournalVaccine
Volume17
Issue number23-24
DOIs
StatePublished - Aug 6 1999

Fingerprint

Secondary Immunization
childhood
Polysaccharides
Immunization
immunization
polysaccharides
immune response
Immunologic Memory
Inactivated Vaccines
infancy
Poliomyelitis
Vaccination
Vaccines
Enzyme-Linked Immunosorbent Assay
vaccines
Control Groups
Antibodies
dosage
Serum
vaccination

Keywords

  • Meningococcus
  • Polysaccharide vaccine
  • Tolerance

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood. / MacLennan, Jenny; Obaro, Stephen; Deeks, Jonathan; Williams, Derrick; Pais, Lorna; Carlone, George; Moxon, Richard; Greenwood, Brian.

In: Vaccine, Vol. 17, No. 23-24, 06.08.1999, p. 3086-3093.

Research output: Contribution to journalArticle

MacLennan, Jenny ; Obaro, Stephen ; Deeks, Jonathan ; Williams, Derrick ; Pais, Lorna ; Carlone, George ; Moxon, Richard ; Greenwood, Brian. / Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood. In: Vaccine. 1999 ; Vol. 17, No. 23-24. pp. 3086-3093.
@article{b624536600304e23b596a2a1b77e4428,
title = "Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood",
abstract = "Forty-two Gambian children randomised to receive two doses of meningococcal A/C polysaccharide vaccine (MPS) in infancy and either MPS (n = 15), meningococcal A/C conjugate (n = 13) or inactivated polio vaccine (IPV n = 14) at 2 years, were revaccinated with MPS at 5 years of age along with 39 matched control children. Meningococcal A and C polysaccharide antibodies were analysed by ELISA and bactericidal assay (SBA) in sera taken before and 10 days after revaccination. The geometric mean group SBA titre in the MPS group following revaccination was about half that of the unvaccinated controls (0.51 95{\%} CI: 0.28, 0.90) for group A and less than half that of the controls for group C (0.41, 95{\%} CI: 0.16, 1.03 P = 0.06). The group C SBA response in the conjugate group was 14-fold higher than in the MPS group (P < 0.001). Multiple doses of meningococcal polysaccharide in childhood may therefore attenuate the SBA response to both group A and group C polysaccharides. In contrast, vaccination with meningococcal A/C conjugate after MPS in infancy gives immunological memory to N. meningitidis group C.",
keywords = "Meningococcus, Polysaccharide vaccine, Tolerance",
author = "Jenny MacLennan and Stephen Obaro and Jonathan Deeks and Derrick Williams and Lorna Pais and George Carlone and Richard Moxon and Brian Greenwood",
year = "1999",
month = "8",
day = "6",
doi = "10.1016/S0264-410X(99)00139-5",
language = "English (US)",
volume = "17",
pages = "3086--3093",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "23-24",

}

TY - JOUR

T1 - Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood

AU - MacLennan, Jenny

AU - Obaro, Stephen

AU - Deeks, Jonathan

AU - Williams, Derrick

AU - Pais, Lorna

AU - Carlone, George

AU - Moxon, Richard

AU - Greenwood, Brian

PY - 1999/8/6

Y1 - 1999/8/6

N2 - Forty-two Gambian children randomised to receive two doses of meningococcal A/C polysaccharide vaccine (MPS) in infancy and either MPS (n = 15), meningococcal A/C conjugate (n = 13) or inactivated polio vaccine (IPV n = 14) at 2 years, were revaccinated with MPS at 5 years of age along with 39 matched control children. Meningococcal A and C polysaccharide antibodies were analysed by ELISA and bactericidal assay (SBA) in sera taken before and 10 days after revaccination. The geometric mean group SBA titre in the MPS group following revaccination was about half that of the unvaccinated controls (0.51 95% CI: 0.28, 0.90) for group A and less than half that of the controls for group C (0.41, 95% CI: 0.16, 1.03 P = 0.06). The group C SBA response in the conjugate group was 14-fold higher than in the MPS group (P < 0.001). Multiple doses of meningococcal polysaccharide in childhood may therefore attenuate the SBA response to both group A and group C polysaccharides. In contrast, vaccination with meningococcal A/C conjugate after MPS in infancy gives immunological memory to N. meningitidis group C.

AB - Forty-two Gambian children randomised to receive two doses of meningococcal A/C polysaccharide vaccine (MPS) in infancy and either MPS (n = 15), meningococcal A/C conjugate (n = 13) or inactivated polio vaccine (IPV n = 14) at 2 years, were revaccinated with MPS at 5 years of age along with 39 matched control children. Meningococcal A and C polysaccharide antibodies were analysed by ELISA and bactericidal assay (SBA) in sera taken before and 10 days after revaccination. The geometric mean group SBA titre in the MPS group following revaccination was about half that of the unvaccinated controls (0.51 95% CI: 0.28, 0.90) for group A and less than half that of the controls for group C (0.41, 95% CI: 0.16, 1.03 P = 0.06). The group C SBA response in the conjugate group was 14-fold higher than in the MPS group (P < 0.001). Multiple doses of meningococcal polysaccharide in childhood may therefore attenuate the SBA response to both group A and group C polysaccharides. In contrast, vaccination with meningococcal A/C conjugate after MPS in infancy gives immunological memory to N. meningitidis group C.

KW - Meningococcus

KW - Polysaccharide vaccine

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0033529658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033529658&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(99)00139-5

DO - 10.1016/S0264-410X(99)00139-5

M3 - Article

C2 - 10462244

AN - SCOPUS:0033529658

VL - 17

SP - 3086

EP - 3093

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 23-24

ER -